Newborn Screening Market worth $ 819.6 Million by 2019 - New Research Report by MarketsandMarkets

North America dominates the newborn screening market. Asia is poised to grow at the highest CAGR during the forecast period owing to support provided by foreign countries for enhancing screening services. http://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

AB SCIEX (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.)

(PRWEB) August 17, 2014

According to a new market research report the "Newborn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019"

Browse 70 market data tables and 16 figures spread through 242 pages and in-depth TOC on "Newborn Screening Market"
http://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html
Early buyers will receive 10% customization on this report.

The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to reach $819.6 million by 2019, growing at a CAGR of 11.0% between 2013 and 2019.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=141676244

The report segments this market based on type, technology, product and geography. Among various technologies, the enzyme assays and immunoassays commanded the largest share in 2013, while tandem mass spectrometry is forecasted to be the fastest-growing segment in this market. Factors such as benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases are driving the growth of the market. Furthermore, owing to continuous advancements in technology, new and innovative devices are being launched in the market, which is another major factor providing impetus for growth of the market.

For Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=141676244

Based on geography, the global market is segmented into North America, South America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the government support in terms of formation of legislation, grants and funding, need for reducing healthcare cost and rising awareness.

The prominent players in this market are AB SCIEX (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).

The key strategies followed by most companies in the newborn screening market are new product launches, agreements, collaborations, partnerships, contracts, acquisitions, approvals, and expansions. Among all growth strategies being adopted by the market players in this field, agreements, collaborations, partnerships, and contracts accounted for the largest share of the overall growth strategies mapped from 2011 to 2014 to leverage the newborn screening market growth opportunities. Some leading players adopting this strategy include AB SCIEX (U.S.), Agilent Technologies (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), PerkinElmer Inc. (U.S.), and Trivitron Healthcare (India). New product launches accounted for the second-largest share of overall growth strategies adopted by players in the market

Browse Related Reports:
High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets


Contact